- Pfizer-BioNtech tells FDA to expand emergency use of its COVID-19 vaccine to Americans between the ages of 5 and 11
- The vaccine is currently fully approved for people 16 years of age and older and is authorized for adolescents 12-15 years of age
- The FDA meeting is up for discussion on October 26th and a decision is expected between Halloween and Thanksgiving
- Parents are split 50/50 on whether or not to vaccinate their children as children make up less than 0.1% of all COVID deaths in the US
Pfizer Inc and its German partner BioNTech SE have asked the US Food and Drug Administration (FDA) to expand emergency use of their COVID-19 vaccine to include children aged five to 11 years.
When the vaccine was originally authorized for use by the FDA in December 2020, it was only for people 16 and older, before being expanded to people 12 and older in May .
The FDA plans to move quickly and a meeting is likely scheduled for October 26 to discuss the matter.
Officials are expected to make a decision between Halloween and Thanksgiving — which will qualify 28 million children.
Some parents eagerly await authorization, while others say they do not want to vaccinate their children because of the low risk of serious disease, which accounts for less than 0.1 percent of all COVID deaths in the US.
scroll down for video
Pfizer-BioNtech asked the FDA to expand emergency use of its COVID-19 vaccine to Americans between the ages of 5 and 11. Image: 9-year-old Marisol Gerardo is held by her mother as she receives her second dose of the Pfizer vaccine during a clinical trial. At Duke Health in Durham, North Carolina, April 2021
The FDA is meeting on October 26 to discuss and a decision is expected between Halloween and Thanksgiving. Pictured: A vial of Pfizer-BioNtech at a pop up vaccine clinic in Los Angeles in August 2021
According to ClinicalTrials.gov, Pfizer’s studies in younger children worked just as well as in older children and adults.
A total of 4,500 young children aged six months and older were enrolled at nearly 100 clinical trial sites in 26 US states, Finland, Poland and Spain.
Of those children, 2,268 were between the ages of five and 11.
In a group of five to 11, about half were given two doses 21 days apart and the other half were given placebo shots.
The team then tested the safety, tolerability and immune response generated by the vaccine by measuring antibody levels in young subjects.
Pfizer said it has selected a lower dose for COVID-19 vaccine trials in children than in adolescents and adults.
People 12 years of age and older get two 30 microgram (μg) doses of the vaccine.
However, a 10 μg dose was given to children aged five to 11 years and a three μg dose to children aged six months to four years.
Unlike the larger clinical trial conducted in adults, the pediatric trial did not measure efficacy by comparing the number of COVID-19 cases among the vaccine group to the number of placebo groups.
Instead, the scientists looked at the levels of neutralizing antibodies in young vaccine recipients and compared the levels to those seen in adults.
The companies expect data on how well the vaccine works in children aged two to five years and those between six months and two years of age by the end of the year.
Most recently, pediatric cases rose from 71,726 per week in early August to more than 243,000 in September, powered by Delta Edition.
However, they are now trending down, with 173,469 reported last week, according to the American Academy of Pediatrics.
There have also been 520 child deaths since the start of the pandemic, indicating that children account for less than 0.1 percent of all deaths.
Currently, no evidence suggests that the delta variant is more dangerous in children than previous strains of the virus.
Because of this low risk of serious illness, surveys have shown that many parents are unwilling to vaccinate their children.
A July 2021 survey conducted by the CS Mott Children’s Hospital National Poll on Children’s Health at Michigan Medicine last month found that 39 percent of parents said their children have already received a coronavirus shot.
However, 40 percent of parents also said that it is ‘unlikely’ that their children will be vaccinated.
one more vote Axios/Ipsos in September found that 44 percent of parents of children aged five to 11 said their children were likely to get vaccinated and 42 percent said it was unlikely their children would be vaccinated. .
A survey by Axios/Ipsos found that 44% percent said their child was likely to get a vaccine and 42% said it was unlikely their children would be vaccinated.
In fact, more children die each year from gun violence, drowning, poisoning and other fatal injuries than those who die from COVID-19.
toxic accidents kill 730 children every yearWith two deaths per day, according to the CDC.
CDC too finds That 2,756 Americans under the age of 19 committed suicide in 2019 and 925 died of drowning.
Another 3,302 children died from traffic-related motor vehicle accidents in 2019.
Not only this, 3,371 children and adolescents lost their lives due to gun violence in the US in 2019. America’s Children’s State 2021 report good.
In 2019, only bicycle accidents accounted for fewer deaths with 79 deaths for those under the age of 20, according to the U.S. US Department of Transportation.
less than 1 in 10 children infected with coronavirus suffer from ‘long covid’
A new study shows that very few children and adolescents infected with COVID-19 have long-term symptoms.
Researchers at Harvard Medical School in Boston, Massachusetts, looked at more than 5,000 under-18s who had contracted the virus.
They found that three to five months after the first test was positive, one in 10 children was battling the so-called ‘long covid’.
Only 15 percent developed symptoms at some point during their infection, with most visible symptoms disappearing within 30 days.
The team says…